Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
May. 14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
Apr. 30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+7.14% | 13.11B | |
+10.78% | 9.55B | |
+1.10% | 5.61B | |
+9.70% | 5.6B | |
+7.41% | 5.26B | |
+33.17% | 5.22B | |
+26.13% | 4.77B | |
+2.65% | 4.09B | |
+5.75% | 4.05B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- Morgan Stanley Double Downgrades Evotec to Underweight From Overweight, Adjusts Price Target to $16 From $23